Terns Pharmaceuticals Inc (TERN)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: TERN Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-04-02	2025-04-01	S Sale	Kuriakose Emil Chief Medical Officer Officer	952 -1.8% 2.49 USD 2,366	952 -1.8%	2.49	USD 2,366
2025-01-06	2025-01-06	PS Planned sale	Quigley Jill M. Non-Executive Director	8,760 -100.0% 5.79 USD 50,758	8,760 -100.0%	5.79	USD 50,758
2025-01-06	2025-01-06	PS Planned sale	Vignola Mark J. Chief Financial Officer Officer	9,059 -10.8% 5.80 USD 52,500	9,059 -10.8%	5.80	USD 52,500
2025-01-06	2025-01-02	S Sale	Quigley Jill M. Non-Executive Director	6,240 -41.6% 5.72 USD 35,702	6,240 -41.6%	5.72	USD 35,702
2025-01-06	2025-01-02	S Sale	Vignola Mark J. Chief Financial Officer Officer	8,129 -8.8% 5.72 USD 46,524	8,129 -8.8%	5.72	USD 46,524
2025-01-06	2025-01-02	S Sale	Kuriakose Emil Chief Medical Officer Officer	4,481 -7.6% 5.71 USD 25,607	4,481 -7.6%	5.71	USD 25,607
2024-12-09	2024-12-05	PP Planned purchase	Burroughs Amy L. Chief Executive Officer Executive Director	15,450 +423.4% 7.15 USD 110,468	15,450 +423.4%	7.15	USD 110,468
2025-02-03	2024-11-30	PP Planned purchase	Jung Melita Sun Chief Business Officer Officer	2,250 +inf% 5.11 USD 11,498	2,250 +inf%	5.11	USD 11,498
2025-02-03	2024-11-30	PP Planned purchase	Burroughs Amy L. Chief Executive Officer Executive Director	510 +2.7% 5.11 USD 2,606	510 +2.7%	5.11	USD 2,606
2024-09-17	2024-09-12	B Purchase	Lu Hongbo Non-Executive Director	285,714 +150.0% 10.50 USD 2,999,997	285,714 +150.0%	10.50	USD 2,999,997
2024-09-17	2024-09-12	B Purchase	Lu Hongbo Non-Executive Director	190,476 +inf% 10.50 USD 1,999,998	190,476 +inf%	10.50	USD 1,999,998
2024-09-12	2024-09-10	PS Planned sale	Vignola Mark J. Chief Financial Officer Officer	10,000 -9.8% 11.00 USD 110,000	10,000 -9.8%	11.00	USD 110,000
2024-09-11	2024-09-09	PS Planned sale	Quigley Jill M. Non-Executive Director	17,235 -53.5% 10.00 USD 172,350	17,235 -53.5%	10.00	USD 172,350
2024-08-05	2024-08-02	PS Planned sale	Quigley Jill M. Non-Executive Director	8,857 -37.1% 7.50 USD 66,432	8,857 -37.1%	7.50	USD 66,432
2024-08-05	2024-08-01	S Sale	Quigley Jill M. Non-Executive Director	6,143 -20.5% 7.68 USD 47,148	6,143 -20.5%	7.68	USD 47,148
2024-07-17	2024-07-16	S Sale	GORDON CARL L Non-Executive Director Large shareholder	623 -0.1% 10.00 USD 6,230	623 -0.1%	10.00	USD 6,230
2024-07-17	2024-07-16	S Sale	GORDON CARL L Non-Executive Director Large shareholder	556 -0.0% 10.00 USD 5,560	556 -0.0%	10.00	USD 5,560
2024-07-17	2024-07-16	S Sale	GORDON CARL L Non-Executive Director Large shareholder	4,009 -0.1% 10.00 USD 40,090	4,009 -0.1%	10.00	USD 40,090
2024-07-17	2024-07-16	S Sale	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	623 -0.1% 10.00 USD 6,230	623 -0.1%	10.00	USD 6,230
2024-07-17	2024-07-16	S Sale	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	556 -0.0% 10.00 USD 5,560	556 -0.0%	10.00	USD 5,560
2024-07-17	2024-07-16	S Sale	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	4,009 -0.1% 10.00 USD 40,090	4,009 -0.1%	10.00	USD 40,090
2024-07-17	2024-07-16	PS Planned sale	Quigley Jill M. Non-Executive Director	400 -1.3% 10.00 USD 4,000	400 -1.3%	10.00	USD 4,000
2024-07-17	2024-07-15	S Sale	GORDON CARL L Non-Executive Director Large shareholder	6,142 -0.8% 10.00 USD 61,420	6,142 -0.8%	10.00	USD 61,420
2024-07-17	2024-07-15	S Sale	GORDON CARL L Non-Executive Director Large shareholder	5,401 -0.3% 10.00 USD 54,010	5,401 -0.3%	10.00	USD 54,010
2024-07-17	2024-07-15	S Sale	GORDON CARL L Non-Executive Director Large shareholder	39,433 -0.8% 10.00 USD 394,330	39,433 -0.8%	10.00	USD 394,330
2024-07-17	2024-07-15	S Sale	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	6,142 -0.8% 10.00 USD 61,420	6,142 -0.8%	10.00	USD 61,420
2024-07-17	2024-07-15	S Sale	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	5,401 -0.3% 10.00 USD 54,010	5,401 -0.3%	10.00	USD 54,010
2024-07-17	2024-07-15	S Sale	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	39,433 -0.8% 10.00 USD 394,330	39,433 -0.8%	10.00	USD 394,330
2024-07-17	2024-07-15	PS Planned sale	Quigley Jill M. Non-Executive Director	14,365 -32.4% 10.00 USD 143,660	14,365 -32.4%	10.00	USD 143,660
2024-06-04	2024-05-31	PP Planned purchase	Vignola Mark J. Chief Financial Officer Officer	4,791 +5.5% 4.44 USD 21,272	4,791 +5.5%	4.44	USD 21,272
2024-06-04	2024-05-31	PP Planned purchase	Yoon Seokho Bryan COO and General Counsel Officer	4,791 +5.5% 4.44 USD 21,272	4,791 +5.5%	4.44	USD 21,272
2024-04-03	2024-04-03	PS Planned sale	Vivo Opportunity, LLC Large shareholder	4,149 -1.5% 6.20 USD 25,724	4,149 -1.5%	6.20	USD 25,724
2024-04-03	2024-04-03	PS Planned sale	Vivo Opportunity, LLC Large shareholder	30,047 -1.5% 6.20 USD 186,291	30,047 -1.5%	6.20	USD 186,291
2024-04-03	2024-04-03	PS Planned sale	Vivo Opportunity, LLC Large shareholder	103,870 -2.5% 6.20 USD 643,994	103,870 -2.5%	6.20	USD 643,994
2024-04-03	2024-04-02	PS Planned sale	Vivo Opportunity, LLC Large shareholder	3,050 -1.1% 6.65 USD 20,283	3,050 -1.1%	6.65	USD 20,283
2024-04-03	2024-04-02	PS Planned sale	Vivo Opportunity, LLC Large shareholder	22,084 -1.1% 6.65 USD 146,859	22,084 -1.1%	6.65	USD 146,859
2024-04-03	2024-04-02	PS Planned sale	Vivo Opportunity, LLC Large shareholder	76,346 -1.8% 6.65 USD 507,701	76,346 -1.8%	6.65	USD 507,701
2024-04-03	2024-04-01	PS Planned sale	Vivo Opportunity, LLC Large shareholder	5,451 -1.9% 6.99 USD 38,102	5,451 -1.9%	6.99	USD 38,102
2024-04-03	2024-04-01	PS Planned sale	Vivo Opportunity, LLC Large shareholder	39,411 -1.9% 6.99 USD 275,483	39,411 -1.9%	6.99	USD 275,483
2024-04-03	2024-04-01	PS Planned sale	Vivo Opportunity, LLC Large shareholder	136,255 -3.1% 6.99 USD 952,422	136,255 -3.1%	6.99	USD 952,422
2023-12-04	2023-11-30	PP Planned purchase	Yoon Seokho Bryan COO and General Counsel Officer	743 +4.2% 3.78 USD 2,809	743 +4.2%	3.78	USD 2,809
2023-12-04	2023-11-30	PP Planned purchase	Vignola Mark J. Chief Financial Officer Officer	743 +4.2% 3.78 USD 2,809	743 +4.2%	3.78	USD 2,809
2023-06-02	2023-05-31	PP Planned purchase	Vignola Mark J. Chief Financial Officer Officer	9,997 +130.5% 1.41 USD 14,096	9,997 +130.5%	1.41	USD 14,096
2023-06-02	2023-05-31	PP Planned purchase	Sundaram Senthil Vel Chief Executive Officer Executive Director	2,111 +27.6% 1.41 USD 2,977	2,111 +27.6%	1.41	USD 2,977
2023-06-02	2023-05-31	PP Planned purchase	Yoon Seokho Bryan COO and General Counsel Officer	9,997 +130.5% 1.41 USD 14,096	9,997 +130.5%	1.41	USD 14,096
2022-12-28	2022-12-23	B Purchase	GORDON CARL L Non-Executive Director Large shareholder	137,931 +2.9% 7.25 USD 1,000,000	137,931 +2.9%	7.25	USD 1,000,000
2022-12-28	2022-12-23	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	137,931 +2.9% 7.25 USD 1,000,000	137,931 +2.9%	7.25	USD 1,000,000
2022-12-23	2022-12-23	B Purchase	Lu Hongbo Non-Executive Director	758,620 +21.2% 7.25 USD 5,499,995	758,620 +21.2%	7.25	USD 5,499,995
2022-12-23	2022-12-23	B Purchase	Vivo Opportunity, LLC Large shareholder	758,620 +21.2% 7.25 USD 5,499,995	758,620 +21.2%	7.25	USD 5,499,995
2023-02-03	2022-11-30	PP Planned purchase	Vignola Mark J. Chief Financial Officer Officer	3 +0.0% 1.41 USD 4	3 +0.0%	1.41	USD 4
2023-02-03	2022-11-30	PP Planned purchase	Yoon Seokho Bryan COO and General Counsel Officer	3 +0.0% 1.41 USD 4	3 +0.0%	1.41	USD 4
2023-02-03	2022-11-30	PP Planned purchase	Sundaram Senthil Vel Chief Executive Officer Executive Director	3 +0.0% 1.41 USD 4	3 +0.0%	1.41	USD 4
2022-11-28	2022-11-23	S Sale	LAV Biosciences Fund V, L.P. Large shareholder	166,666 -23.9% 5.50 USD 916,663	166,666 -23.9%	5.50	USD 916,663
2022-11-28	2022-11-23	S Sale	LAV Biosciences Fund V, L.P. Large shareholder	333,334 -23.9% 5.50 USD 1,833,337	333,334 -23.9%	5.50	USD 1,833,337
2022-11-28	2022-11-23	S Sale	LAV Biosciences Fund V, L.P. Large shareholder	1,000,000 -71.1% 5.50 USD 5,500,000	1,000,000 -71.1%	5.50	USD 5,500,000
2022-09-08	2022-09-07	B Purchase	Vivo Opportunity, LLC Large shareholder	600,000 +20.1% 3.60 USD 2,160,000	600,000 +20.1%	3.60	USD 2,160,000
2022-09-08	2022-09-07	B Purchase	Lu Hongbo Non-Executive Director	600,000 +20.1% 3.60 USD 2,160,000	600,000 +20.1%	3.60	USD 2,160,000
2022-08-18	2022-08-16	B Purchase	GORDON CARL L Non-Executive Director Large shareholder	762,400 +inf% 2.42 USD 1,845,008	762,400 +inf%	2.42	USD 1,845,008
2022-08-18	2022-08-16	B Purchase	GORDON CARL L Non-Executive Director Large shareholder	457,400 +30.2% 2.42 USD 1,106,908	457,400 +30.2%	2.42	USD 1,106,908
2022-08-18	2022-08-16	B Purchase	GORDON CARL L Non-Executive Director Large shareholder	2,470,200 +108.6% 2.42 USD 5,977,884	2,470,200 +108.6%	2.42	USD 5,977,884
2022-08-18	2022-08-16	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	762,400 +inf% 2.42 USD 1,845,008	762,400 +inf%	2.42	USD 1,845,008
2022-08-18	2022-08-16	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	457,400 +30.2% 2.42 USD 1,106,908	457,400 +30.2%	2.42	USD 1,106,908
2022-08-18	2022-08-16	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	2,470,200 +108.6% 2.42 USD 5,977,884	2,470,200 +108.6%	2.42	USD 5,977,884
2022-08-16	2022-08-16	B Purchase	Lu Hongbo Non-Executive Director	1,500,000 +101.2% 2.42 USD 3,630,000	1,500,000 +101.2%	2.42	USD 3,630,000
2022-08-16	2022-08-16	B Purchase	Vivo Opportunity, LLC Large shareholder	1,500,000 +101.2% 2.42 USD 3,630,000	1,500,000 +101.2%	2.42	USD 3,630,000
2022-08-16	2022-08-15	B Purchase	Lu Hongbo Non-Executive Director	1,218 +0.1% 2.99 USD 3,642	1,218 +0.1%	2.99	USD 3,642
2022-08-16	2022-08-15	B Purchase	Vivo Opportunity, LLC Large shareholder	1,218 +0.1% 2.99 USD 3,642	1,218 +0.1%	2.99	USD 3,642
2022-08-16	2022-08-12	B Purchase	Lu Hongbo Non-Executive Director	1,123,021 +314.3% 2.98 USD 3,346,603	1,123,021 +314.3%	2.98	USD 3,346,603
2022-08-16	2022-08-12	B Purchase	Vivo Opportunity, LLC Large shareholder	1,123,021 +314.3% 2.98 USD 3,346,603	1,123,021 +314.3%	2.98	USD 3,346,603
2022-06-08	2022-05-31	PP Planned purchase	Vignola Mark J. Chief Financial Officer Officer	7,656 +inf% 1.47 USD 11,254	7,656 +inf%	1.47	USD 11,254
2022-06-08	2022-05-31	PP Planned purchase	Yoon Seokho Bryan COO and General Counsel Officer	7,656 +inf% 1.47 USD 11,254	7,656 +inf%	1.47	USD 11,254
2022-06-08	2022-05-31	PP Planned purchase	Sundaram Senthil Vel Chief Executive Officer Executive Director	7,656 +inf% 1.47 USD 11,254	7,656 +inf%	1.47	USD 11,254
2021-02-09	2021-02-09	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	285,000 +14.3% 17.00 USD 4,845,000	285,000 +14.3%	17.00	USD 4,845,000
2021-02-09	2021-02-09	B Purchase	ORBIMED ADVISORS LLC Non-Executive Director Large shareholder	190,000 +14.3% 17.00 USD 3,230,000	190,000 +14.3%	17.00	USD 3,230,000
2021-02-09	2021-02-09	B Purchase	Vivo Capital VIII, LLC Large shareholder	357,353 +inf% 17.00 USD 6,075,001	357,353 +inf%	17.00	USD 6,075,001

Terns Pharmaceuticals Inc (TERN)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by